What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment
- PMID: 33780499
- PMCID: PMC8007023
- DOI: 10.1371/journal.pone.0249298
What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment
Abstract
Background: Follow-up after low-risk basal cell carcinoma (BCC) is being provided more frequently than recommended by guidelines. To design an acceptable strategy to successfully reduce this 'low-value' care, it is important to obtain insights into the preferences of patients and dermatologists.
Objective: To determine the preferences and needs of patients and dermatologists to reduce low-risk BCC follow-up care, and the trade-offs they are willing to make.
Methods: A questionnaire including a discrete choice experiment was created, containing attributes regarding amount of follow-up, continuity of care, method of providing addition information, type of healthcare provider, duration of follow-up visits and skin examination. In total, 371 BCC patients and all Dutch dermatologists and dermatology residents (n = 620) were invited to complete the questionnaire. A panel latent class model was used for analysis.
Results: Eighty-four dermatologists and 266 BCC patients (21% and 72% response rates respectively) completed the discrete choice experiment. If the post-treatment visit was performed by the same person as treatment provider and a hand-out was provided to patients containing personalised information, the acceptance of having no additional follow-up visits (i.e. following the guidelines) would increase from 55% to 77% by patients. Female patients and older dermatologists, however, are less willing to accept the guidelines and prefer additional follow-up visits.
Limitations: The low response rate of dermatologists.
Conclusion: This discrete choice experiment revealed a feasible strategy to substantially reduce costs, while maintaining quality of care, based on the preferences and needs of BCC patients, which is supported by dermatologists.
Conflict of interest statement
We understand that VGZ must be explicitly mentioned as a commercial funder. We would like to alter our Competing Interest Statement to: “The authors and funders (Dutch Ministry of Health, Welfare and Sport and the health insurance company VGZ) have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures


Similar articles
-
Preferences of cancer survivors for follow-up care: a systematic review of discrete choice experiments.BMC Health Serv Res. 2024 Dec 2;24(1):1519. doi: 10.1186/s12913-024-12000-0. BMC Health Serv Res. 2024. PMID: 39617909 Free PMC article.
-
Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.Br J Dermatol. 2019 Jun;180(6):1420-1429. doi: 10.1111/bjd.17594. Epub 2019 Mar 28. Br J Dermatol. 2019. PMID: 30597525 Free PMC article.
-
What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.BMC Dermatol. 2012 Oct 4;12:19. doi: 10.1186/1471-5945-12-19. BMC Dermatol. 2012. PMID: 23035730 Free PMC article. Clinical Trial.
-
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.PLoS One. 2022 Jan 24;17(1):e0260978. doi: 10.1371/journal.pone.0260978. eCollection 2022. PLoS One. 2022. PMID: 35073333 Free PMC article.
-
Patient Preferences for the Treatment of Basal Cell Carcinoma: A Mapping Review of Discrete Choice Experiments.Dermatol Surg. 2018 Aug;44(8):1041-1049. doi: 10.1097/DSS.0000000000001564. Dermatol Surg. 2018. PMID: 30045140 Review.
Cited by
-
Preferences of cancer survivors for follow-up care: a systematic review of discrete choice experiments.BMC Health Serv Res. 2024 Dec 2;24(1):1519. doi: 10.1186/s12913-024-12000-0. BMC Health Serv Res. 2024. PMID: 39617909 Free PMC article.
-
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.Pharmacoeconomics. 2025 Aug;43(8):879-936. doi: 10.1007/s40273-025-01495-y. Epub 2025 May 21. Pharmacoeconomics. 2025. PMID: 40397369 Free PMC article.
-
Factors associated with patients' demand for low-value care: a scoping review.BMC Health Serv Res. 2024 Dec 28;24(1):1656. doi: 10.1186/s12913-024-12093-7. BMC Health Serv Res. 2024. PMID: 39731121 Free PMC article.
References
-
- Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP). 2015;24(2):141–9. Epub 2014/08/05. 10.1097/CEJ.0000000000000056 - DOI - PubMed
-
- Leavitt M. Medscape’s response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century. MedGenMed: Medscape general medicine. 2001;3(2):2. Epub 2001/09/11. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical